Results by Bastien et al.[9] show that ER, PR and HER2 staining are relatively homogeneous within luminal A cancers (more than 93% and 94% of luminal A cancers are ER- and PR-positive, respectively, and more than 99% of these tumors are HER2-negative). The gene discussed is PGR; the disease is cancer.